Exacerbations: number of people experiencing moderate or severe exacerbations · treatment for asthma in adults and children with asthma and GORD
Medical or surgical intervention, or both, for gastro‐oesophageal… showed no clear difference in number of participants with moderate/severe acute exacerbations… compared with nil intervention, delayed intervention control, or placebo (low certainty).
1 finding from 1 review
Cosmetic appearance · participants with varicose veinsa
1 finding from 1 review
Intervention not reported
MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMRV randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ · children 9 months to 15 years old
The intervention leads to lower MMR+V randomised controlled trial ‐ moderate/severe cases ‐ 2 doses ‐ (high certainty).
1 finding from 1 review
Intervention not reported
Cohort studies ‐ autism risk (moderate/high), MMR · children 9 months to 15 years old
The intervention may leads to lower cohort studies ‐ autism risk (moderate/high), MMR (low certainty).
1 finding from 1 review
OHSS · Women undergoing ovarian stimulation with gonadotrophins in IVF and ICSI procedures
Monitoring ovarian stimulation by transvaginal ultrasound (TVUS) only showed no clear difference in OHSS rate (mild, moderate or severe) per woman compared with monitoring with TVUS plus serum estradiol (low certainty).
1 finding from 1 review
Severity of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Intervention not reported
Moderate to vigorous physical activity (minutes/d) [ · children and adolescents aged 6 to 18 years
1 finding from 1 review
Moderate or severe OHSS · women undergoing assisted reproduction
Dopamine agonist probably leads to lower incidence of moderate or severe OHSS compared with placebo/no intervention (moderate certainty).
1 finding from 1 review
Moderate or severe OHSS · women undergoing assisted reproduction
It is very uncertain whether dopamine agonist changes incidence of moderate or severe OHSS compared with other active intervention (very low certainty).
1 finding from 1 review
Moderate or severe OHSS · women undergoing assisted reproduction
Dopamine agonist plus co‐intervention may leads to lower incidence of moderate or severe OHSS compared with co‐intervention (low certainty).
1 finding from 1 review
Adverse events (moderate) · adolescent and adult male circumcisions
Circumcision devices showed no clear difference in moderate adverse events compared with standard surgical techniques (low certainty).
1 finding from 1 review
Moderate to severe hypoxic‐ischaemic encephalopathy (HIE) · non‐vigorous neonates born through meconium‐stained amniotic fluid
It is very uncertain whether tracheal suction changes moderate to severe hypoxic‐ischaemic encephalopathy (HIE) compared with no tracheal suction (very low certainty).
1 finding from 1 review
Persistent moderate to severe symptoms at 12 to 24 weeks · adults (> 18 years of age) with trigger finger
NSAID injection may leads to higher persistent moderate to severe symptoms at 12 to 24 weeks compared with glucocorticoid injection (low certainty).
1 finding from 1 review
Number of people experiencing at least 1 exacerbation/moderate to severe exacerbation · patients with chronic obstructive pulmonary disease
It is very uncertain whether multi‐component interventions (with telehealth as a component of care) changes number of people experiencing at least 1 exacerbation/moderate to… compared with usual care (very low certainty).
1 finding from 1 review
Intervention not reported
Total daily moderate‐to‐vigorous physical activity (MVPA) · health problem or population
1 finding from 1 review